These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3512970)

  • 1. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate.
    Bezwoda WR; Nissenbaum M; Derman DP
    Med Pediatr Oncol; 1986; 14(1):17-9. PubMed ID: 3512970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
    Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
    Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-cisplatin combination chemotherapy for recurrent carcinoma of the cervix.
    Tropé C; Horvath G; Haadem K; Gudmundsson T; Simonsen E
    Cancer Treat Rep; 1986 Nov; 70(11):1325-6. PubMed ID: 3768874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR; Myers M
    Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
    Vogl SE; Seltzer V; Camacho F; Davis TE
    J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
    Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
    Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
    Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
    Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
    Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapy.
    Hardy JR; Maclean GD; Foote GA; Harvey VJ
    Aust N Z J Obstet Gynaecol; 1987 May; 27(2):146-9. PubMed ID: 2445332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the chemotherapy of patients with recurrence of cervical cancer after radiotherapy].
    Sablińska B; Cześnin K
    Ginekol Pol; 1986 Mar; 57(3):218-22. PubMed ID: 3732857
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix: A Retrospective Analysis.
    Choi HJ; Paik ES; Choi CH; Kim TJ; Lee YY; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2018 Sep; 28(7):1333-1341. PubMed ID: 30045137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix.
    Lorvidhaya V
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():252-5. PubMed ID: 7661592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
    Papadimitriou CA; Dimopoulos MA; Giannakoulis N; Sarris K; Vassilakopoulos G; Akrivos T; Voulgaris Z; Vlahos G; Diakomanolis E; Michalas S
    Cancer; 1997 Jun; 79(12):2391-5. PubMed ID: 9191528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix.
    Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS
    Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
    Shimada M; Sato S; Oishi T; Itamochi H; Kigawa J; Takeshima N; Aoki D; Aoki Y; Nambu Y; Ochiai K
    Int J Clin Oncol; 2016 Oct; 21(5):969-974. PubMed ID: 27142771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).
    Adamo V; Altavilla G; Buemi B; Caristi N; Scalisi R; Tropea F
    Chemioterapia; 1985 Apr; 4(2):143-6. PubMed ID: 2408771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.